SCINAI IMMUNOTHERAPEUTICS LTD. Increase Decrease In Operating Lease Liability
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) reported Increase Decrease In Operating Lease Liability of $147.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-04-01
- SCINAI IMMUNOTHERAPEUTICS LTD. increase decrease in operating lease liability for the quarter ending 2023-06-30 was -$4.00K, a 105.63% decline year-over-year.
- SCINAI IMMUNOTHERAPEUTICS LTD. increase decrease in operating lease liability for the quarter ending 2023-03-31 was $7.00K.
- SCINAI IMMUNOTHERAPEUTICS LTD. increase decrease in operating lease liability for the quarter ending 2022-06-30 was $71.00K.
- SCINAI IMMUNOTHERAPEUTICS LTD. increase decrease in operating lease liability for the quarter ending 2022-03-31 was -$62.00K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|
| 2025-12-31 | $147.00K 20-F · filed 2026-04-01 | ||
| 2025-06-30 | $237.00K 6-K · filed 2025-09-02 | ||
| 2024-12-31 | -$314.00K 20-F · filed 2026-04-01 | ||
| 2024-06-30 | -$189.00K 6-K · filed 2025-09-02 | ||
| 2023-12-31 | -$58.00K 20-F · filed 2026-04-01 | ||
| 2023-06-30 | -$4.00K derived: 6-K 6 month − 10-Q 3 month · filed 2024-09-09 | $3.00K 6-K · filed 2024-09-09 | |
| 2023-03-31 | $7.00K 10-Q · filed 2023-05-15 | ||
| 2022-12-31 | -$156.00K 20-F · filed 2025-05-07 | ||
| 2022-06-30 | $71.00K derived: 6-K/A 6 month − 10-Q 3 month · filed 2023-08-18 | $9.00K 6-K/A · filed 2023-08-18 | |
| 2022-03-31 | -$62.00K 10-Q · filed 2023-05-15 | ||
| 2021-12-31 | -$150.00K 20-F · filed 2024-05-15 |